Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
According to DataHorizzon Research, the Active Pharmaceutical Ingredients (API) Market size was valued at USD 151.2 Billion in 2022 and is expected to reach USD 346.4 Billion by 2032 at a CAGR of 8.7%.
read more
Avid Bioservices, Inc. , a biologics contract development and manufacturing organization (CDMO) announced that it has completed construction of CGMP manufacturing suites within its new, world-class cell and gene therapy (CGT) development and CGMP ...
read more
Aldena Therapeutics, a private biotech company pioneering siRNA- based therapies for dermatological indications, has chosen PCI Pharma Services (PCI), a global contract development and manufacturing organization (CDMO) to formulate, package, and ...
read more
Andelyn Biosciences, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Purespring Therapeutics, a biotech company, to accelerate the manufacture of their gene therapies for the treatment of ...
read more
Thursday, October 19, 2023
Oxford Nanopore and bioMérieux SA announced that bioMérieux is making an immediate £70M investment in Oxford Nanopore.
In addition, bioMérieux expects to make further market purchases of Oxford Nanopore’s shares from time to time, up to a further 3....
read more
Thursday, October 19, 2023
As of November 1st, 2023, Dr. Stephan Haitz will assume the role of President of the Novasep CDMO Business Unit and will become a member of the company's Executive Committee, succeeding Jean Bléhaut, who is departing the company after a distinguished...
read more
Thursday, October 19, 2023
Veristat, a scientific full-service clinical research organization (CRO) and consultancy acquired Instat Clinical Research, a biometrics CRO with a 20-year track record of transforming complex data into precise study results.
read more
Thursday, October 19, 2023
Aragen, a leading provider of contract research, development, and manufacturing services for the pharmaceutical, biotechnology, agrochemicals, and animal health sectors, has inaugurated its advanced formulations manufacturing facility in Hyderabad, ...
read more
Wednesday, October 18, 2023
Piramal Pharma Limited’s Pharma Solutions (PPS) business announced the launch of a high-throughput screening facility that augments the existing in-vitro biology capabilities at its drug discovery services site in Ahmedabad, India.
read more
Tuesday, October 17, 2023
Semi-solids for pharmaceuticals, medical devices, and cosmetics, as well as non-sterile liquids, continue to experience increasing demand. To meet these growing market needs, Aenova, a contract development and manufacturing organization (CDMO), is ...
read more
Tuesday, October 17, 2023
Vetter has announced additional investments as part of its long-term dedication to customer partnerships. Vetter’s extensive 40+ years of experience in aseptic filling and packaging shows a consistent desire for sustainable growth and corporate ...
read more
Tuesday, October 17, 2023
WuXi Biologics has launched a new proprietary bioprocessing platform WuXiUI™, an ultra-intensified, fed-batch solution that enhances the productivity and quality of multiple different CHO or other mammalian cell lines and product modalities.
read more
Tuesday, October 17, 2023
P95 BV, a portfolio company of Ampersand Capital Partners and leading provider of clinical and observational services to vaccine developers, has signed an agreement to merge OnQ Research into P95.
read more
Navin Fluorine International Ltd (NFIL)., part of the Padmanabh Mafatlal Group, announced the new identity for its contract development and manufacturing division, Navin Molecular.
read more
Quotient Sciences announced the appointment of Thierry Van Nieuwenhove as its new Chief Executive Officer (CEO), effective 16th October 2023.
read more